ALIAXIN SR Injection Solution for

What is ALIAXIN SR

ALIAXIN SR (Shape & Restore) is a sterile dermal filler formulated with 25 mg/mL of ultrapure, non-animal cross-linked **hyaluronic acid (HA)**, supplied in dual 1 mL pre-filled syringes with included 27G and 30G needles :contentReference[oaicite:1]{index=1}. :contentReference[oaicite:2]{index=2} :contentReference[oaicite:3]{index=3}.

• Target indications: Facial contouring and restoration—ideal for medium to deep wrinkles (e.g., nasolabial folds, chin definition, cheek volumizing), as well as subtle enhancement of delicate areas (e.g., tear troughs) :contentReference[oaicite:4]{index=4}.
• Biointegration benefits: The gel’s visco-elastic profile allows for even tissue integration, providing lifting while supporting microcirculation and gradual collagen stimulation :contentReference[oaicite:5]{index=5}.
• Longevity: Clinically demonstrated results lasting up to 6–9 months, with structural stability and resilience in dynamic facial zones :contentReference[oaicite:6]{index=6}.
• Structure & flow: Monophasic, non-animal HA ensures optimal cohesivity, spreading, and reduced nodularity :contentReference[oaicite:7]{index=7}.

In summary, ALIAXIN SR is a versatile filler for aesthetic practitioners seeking to combine facial reshaping, depth correction, and long-term skin revitalization with high compatability and low risk.

How to use ALIAXIN SR

ALIAXIN SR is intended for professional use and should be administered under strict aseptic conditions.

• Preparation: Inspect packaging, confirm expiry, cleanse skin with alcohol-based antiseptic; avoid benzalkonium chloride :contentReference[oaicite:8]{index=8}.
• Needle choice: Supplied with 27G × 13 mm and 30G × 19 mm needles—select based on target depth.
• Injection techniques: Employ bolus or linear threading for volumizing; micro-puncture for contour finesse; mid-to-deep dermis depth recommended :contentReference[oaicite:9]{index=9}.
• Treatment areas: Nasolabial folds, cheeks, chin, jawline, and tear troughs (advanced technique area) :contentReference[oaicite:10]{index=10}.
• Dosing: Typically 1 mL per session; both syringes may be used across separate zones according to aesthetic objectives :contentReference[oaicite:11]{index=11}.
• Post-care: Light massage for gel distribution, ice to reduce swelling/bruising, avoid makeup and strenuous activity for 24 h :contentReference[oaicite:12]{index=12}.
• Follow-up: Evaluate results and consider touch-up at 2–4 weeks.
• Documentation: Record batch numbers, injected volumes, and areas treated for traceability.

Precision injection, sterile handling, and clear aftercare protocols are essential to achieve consistent, safe results.

Mode of Action ALIAXIN SR

ALIAXIN SR provides both mechanical support and skin-enhancing biochemical effects:

• Structural volume: Cross-linked HA gel creates lift and contour by physically filling dermal or subcutaneous spaces :contentReference[oaicite:13]{index=13}.
• Hydration: HA binds water—up to 1,000× its own weight—enhancing skin turgor and elasticity :contentReference[oaicite:14]{index=14}.
• Biointegration: Monophasic, cohesive gel integrates seamlessly with tissue, minimizing migration and promoting a natural appearance :contentReference[oaicite:15]{index=15}.
• Collagen stimulation: Gradual mechanical stress and local HA presence may stimulate fibroblast activity, supporting dermal remodeling :contentReference[oaicite:16]{index=16}.
• Biodegradation: The HA matrix naturally degrades over months, enabling gradual loss of effect while maintaining skin quality improvements :contentReference[oaicite:17]{index=17}.

This dual-mode action results in visible volume restoration and improved dermal texture, with results lasting approximately 6–9 months.

ALIAXIN SR Interactions ALIAXIN SR

Systemic drug interactions are minimal, but local factors should be considered:

• Antiseptics: Avoid quaternary ammonium compounds; use alcohol-based products for skin cleansing :contentReference[oaicite:18]{index=18}.
• Anticoagulants/NSAIDs: These may increase the risk or severity of bleeding and bruising post-injection; advise cessation for 24–48 hours before treatment :contentReference[oaicite:19]{index=19}.
• Cosmetic procedures: Do not perform laser treatments, peels, or micro-needling at or near injection sites within one week to avoid inflammation escalation.
• Hyaluronidase: Useful for reversing unwanted outcomes (e.g., overcorrection or vascular compromise); should be available during treatment :contentReference[oaicite:20]{index=20}.
• Vaccinations: Defer filler injections at treated sites around vaccination dates to avoid additive inflammation.

By optimizing procedural timing and managing local factors, practitioners can improve safety and minimize complications.

Dosage of ALIAXIN SR

• Available volume: 2 × 1 mL pre-filled syringes per kit :contentReference[oaicite:21]{index=21}.
• Typical dosing: 0.5–1 mL per area, depending on restoration needs; practitioners may use both syringes in separate facial zones per session.
• Depth guidance: Mid-dermis for superficial correction, deeper for volumizing areas; use needle gauge based on target depth :contentReference[oaicite:22]{index=22}.
• Micro-dosing: Use small aliquots along folds or superficially to achieve smooth, natural results.
• Maintenance protocol: Single session—with optional top-up at 2–4 weeks; repeat every 6–9 months based on degradation and patient desires :contentReference[oaicite:23]{index=23}.
• Session planning: Avoid overcorrection—focus on gradual enhancements with potential follow-up session.

Personalized dosing ensures tailored aesthetics while optimizing safety and longevity of outcomes.

Possible side effects of ALIAXIN SR

• Common, transient (within 72 hrs): Redness, swelling, bruising, tenderness, itching at injection site—resolving within days :contentReference[oaicite:24]{index=24}.
• Localized lumps/nodules: Usually mild, resolve spontaneously or via massage; can be managed with small hyaluronidase injections if persistent :contentReference[oaicite:25]{index=25}.
• Rare complications: Infection, granuloma formation, vascular occlusion—presenting with pain, pallor, or more severe symptoms and requiring urgent intervention :contentReference[oaicite:26]{index=26}.
• Allergic reactions: Very uncommon with non-animal HA; monitor for signs of hypersensitivity.
• Systemic reactions: Essentially nonexistent—HA remains localized; systemic adverse events are rare.

Most side effects are mild and self-limited; however, practitioners must be prepared for rare but serious adverse events by having hyaluronidase and emergency protocols in place.

ALIAXIN SR Contraindications ALIAXIN SR

• Absolute contraindications:
  • Known hypersensitivity to hyaluronic acid, lidocaine (if included), or filler excipients :contentReference[oaicite:27]{index=27}.
  • Active infection or inflammation (e.g., acne, herpes, cellulitis) at treatment site.
  • Bleeding diathesis or use of anticoagulants that cannot be paused :contentReference[oaicite:28]{index=28}.
• Relative contraindications:
  • Pregnancy or breastfeeding—insufficient data.
  • Autoimmune disorders—assess on a case-by-case basis.
  • Immune-compromised individuals—use caution.
  • Trend for poor wound healing—risk assessment advised.

Conduct thorough patient screening and medical history review prior to injection to mitigate risk.

Storage of ALIAXIN SR

• Temperature: Store between 2 °C and 25 °C; avoid freezing or overheating :contentReference[oaicite:29]{index=29}.
• Packaging: Keep in original sealed blister until use to protect sterility and efficacy.
• Sterility: Syringes are single-use; discard any remaining product after injection.
• Expiry: Use before the printed expiration date; do not use expired units.
• Disposal: Dispose of syringes and needles as medical waste in accordance with regulations.

Proper storage and handling maintain product stability, sterility, and treatment safety.